fda removes tirzepatide from shortage list The Outsourcing Facilities Association (OFA) is suing the after the agency removed (Zepbound, Mounjaro) the federal drug without proper notice. The lawsuit claims that the FDA failed Lilly's weight-loss drug removed from
Description
Compounding pharmacies offer copycat weight-loss drugs to millions, although FDA spokesperson warns against potential contamination or counterfeit.
Use intermittently (every other day) or as directed by your healthcare provider
GLP-3 RT(LY3437943) for laboratory research into GLP-1/GIP/glucagon triple agonism, glucose metabolism, and energy balance studies
Patients should be fully informed about gastrointestinal discomfort and more severe side effects like pancreatitis and thyroid tumors before beginning the treatment.
